| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4277159 | Urology Practice | 2015 | 9 Pages |
Abstract
Intermittent androgen deprivation therapy has not been widely used in American urology practice. Its adoption shows substantial variation by geographic regions. These regional differences likely reflect uncertainty regarding the efficacy of this therapy among providers as well as differences in patient preferences and involvement in treatment decision making.
Keywords
GnRHNCIPSAU.S.ADTPCAProstate specific antigenPhysician's practice patternsUnited StatesADT, Androgen deprivation therapyProstate cancerSEERNeoplasm recurrenceNeoplasm metastasisLocalNational Cancer InstituteProstatic neoplasmsSurveillance, Epidemiology and End ResultsGonadotropin-releasing hormoneUnited Kingdom
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Huei-Ting Tsai, David Penson, George Luta, John H. Lynch, Yingjun Zhou, Arnold L. Potosky,